‘Made in India’ Covaxin gets emergency use approval for children aged 2-18 years
In a notable moment for India's vaccination program, Bharat Biotech's COVAXIN has received emergency use approval for being administered to ...
In a notable moment for India's vaccination program, Bharat Biotech's COVAXIN has received emergency use approval for being administered to ...
The second phase of human trials for the intra-nasal COVID vaccine, BBV 154, has started in Kanpur from today onwards. ...